GSM-779690T

DRUG2 trials

Sponsors

Acta Pharmaceuticals, Inc, Acta Pharmaceuticals

Conditions

Alzheimer DiseaseHealthy Adult Participants

Phase 1

A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants

WithdrawnNCT07155980

Acta Pharmaceuticals, IncHealthy Adult Participants

Start: 2025-11-09End: 2026-07-11Updated: 2026-01-07

A Study of GSM-779690T in Healthy Adult Participants

Not yet recruitingNCT07690228

Acta PharmaceuticalsAlzheimer Disease, Healthy Adult Participants

Start: 2026-08-15End: 2027-07-15Target: 72Updated: 2026-07-09